Live

Watch CBSN Live

Amylin's Eastham Says Eastbourne's Behrens Is Not Telling the Truth About $20 Share Bid

Amylin director Karin Eastham has, in essence, called Eastbourne Capital board candidate M. Kathleen Behrens a liar (or at least an amnesiac).

On May 11, Behrens had written to Amylin decrying the company's "baseless accusation[s]" and "innuendo"; she alleged Amylin was spreading a rumor that she wanted to see Amylin acquired by another company at $20 a share. Behrens insisted that she wants no such thing.

Today, Eastham wrote back to Behrens to say, Yeah, you did say that:

You may recall that you and I had a phone conversation on January 22, 2009 ... During that conversation, we discussed the topic of a potential sale of the Company and you expressed an interest and willingness to sell Amylin at a price of $20 a share ...

I listened very carefully to your perspective and respectfully assure you that you did in fact state your willingness to sell Amylin for $20 a share.

Amylin is attempting to fend off a challenge for control of its board by Eastbourne and investor Carl Icahn; both believe the company's stock has fallen too low. A shareholder vote is scheduled for the end of this month.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.